Metraipolis › archive › dc_ed96addb3350

Long-Term Disease Control With Second-Line Nivolumab Monotherapy in Malignant Pleural Mesothelioma: A Case Report — Europe PMC PMID:42388949

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42388949
DOI
10.7759/cureus.110026
License (as archived)
solo-consultazione
Archived
2026-10-31T22:53:28.194Z
SHA-256 of the archived text
8a3a1f36932df038c5985c3da9b68479385d76c8d789d7f5061ea6db568c4009
Stable URL of this page
https://metraipolis.com/documento/dc_ed96addb3350

How to cite

Long-Term Disease Control With Second-Line Nivolumab Monotherapy in Malignant Pleural Mesothelioma: A Case Report — Europe PMC PMID:42388949 — Europe PMC (en), https://europepmc.org/article/MED/42388949 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_ed96addb3350 (Metraipolis archive dc_ed96addb3350, sha256 8a3a1f36932df038c5985c3da9b68479385d76c8d789d7f5061ea6db568c4009)
BibTeX
@misc{dced96addb3350,
  title = {Long-Term Disease Control With Second-Line Nivolumab Monotherapy in Malignant Pleural Mesothelioma: A Case Report — Europe PMC PMID:42388949},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42388949},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_ed96addb3350; sha256 8a3a1f36932df038c5985c3da9b68479385d76c8d789d7f5061ea6db568c4009},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42388949. Agents can read the archived copy with the MCP tool read_document.